Last reviewed · How we verify
NCT06180746: ECEMSo
Study of the Conditions of the Effects of Health Mediation on Underserved Population
NA trial testing Knowledge mobilization to facilitate the structuring of health mediation in Mediation in 1,041 participants. Status unknown.
15 September 2024
Quick facts
| Lead sponsor | University Hospital, Bordeaux |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 1,041 |
| Start date | 15 December 2023 |
| Primary completion | 15 September 2024 |
| Estimated completion | 15 September 2024 |
Drugs / interventions tested
- Knowledge mobilization to facilitate the structuring of health mediation
Conditions studied
- Mediation — all drugs for Mediation →
Sponsor
University Hospital, Bordeaux
Who can join
Adults 18 to 99, any sex, with Mediation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators are conducting a longitudinal mixed-method intervention study with a multi-center, multi-case explanatory sequential design. The ECEMSo study aims to identify the impact of health mediation on fostering healthcare utilization, in particular organized cancer screening uptake, by underserved populations living in informal housing in France.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Realist evaluation of the impact of health mediation on underserved populations’ healthcare utilization and cancer screening uptake: the ECEMSo case study protocol
Richard E, Perret G, Ramiz L, Chaves FQ, et al · · 2024 · DOI 10.21203/rs.3.rs-3937146/v1
Verify or expand the search:
- PubMed search for NCT06180746
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital, Bordeaux trials
Trials by the same sponsor.
- NCT07506928 — NEURO - Prognostication Using Late Somatosensory Evoked - Potentials · NA · not yet recruiting
- NCT07524036 — Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan. · NA · not yet recruiting
- NCT07527494 — Digital MEDIcal TWIN for the Prediction of Arrhythmic Sudden Cardiac Death After a Myocardial Infarction · NA · not yet recruiting
- NCT07527442 — Efficacy and Safety of Circumcision Alone on Risk of Febrile Urinary Tract Infections in Boys With Posterior Urethral Va · Phase 2 · not yet recruiting
- NCT07478523 — FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06180746 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Bordeaux
- Last refreshed: 22 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06180746.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing